Home Featured

Featured

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book ‘The Nature of Drugs’

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

Cybin Files its 12th Patent Further Strengthening IP Portfolio of Novel Psychedelic Molecules and Delivery Mechanisms

PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the...

This is the Difference Between Psilocybin and LSD

Horizons ETFs Completes Rebalance of World’s First Psychedelics ETF

Champignon Brands Announces Filing of Listing Statement

Former Vancouver Firefighter Declares Psychedelic Drug Saved His Life

Psychedelic Research Bulletin: March 2021

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

12 3...237 Page 1 of 237

The Premiere of our New Short Film Vital Psychedelic Training: Creating...

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

Sunstone Therapies Announces Expansion of Innovative Dyad Study

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book ‘The Nature of Drugs’

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

Cybin Files its 12th Patent Further Strengthening IP Portfolio of Novel Psychedelic Molecules and Delivery Mechanisms

DMT Pricing Guide

Mapping the DMT Experience

PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the...

This is the Difference Between Psilocybin and LSD

Horizons ETFs Completes Rebalance of World’s First Psychedelics ETF

Interview With Ronan Levy

Champignon Brands Announces Filing of Listing Statement

Former Vancouver Firefighter Declares Psychedelic Drug Saved His Life

Psychedelic Research Bulletin: March 2021

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

EDITOR PICKS

The Premiere of our New Short Film Vital Psychedelic Training: Creating...

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

Sunstone Therapies Announces Expansion of Innovative Dyad Study

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

POPULAR CATEGORY